Literature DB >> 25449991

Effect of structured home-based exercise on walking ability in patients with peripheral arterial disease: a meta-analysis.

Yonghui Li1, Zilun Li1, Guangqi Chang1, Mian Wang1, Ridong Wu1, Shenming Wang2, Chen Yao3.   

Abstract

BACKGROUND: The present study is designed to investigate the effect of structured home-based exercise (SHE) programs on maximal walking time (MWT), pain-free walking time (PFWT), and self-reported walking ability in patients with peripheral arterial disease (PAD).
METHODS: We searched the databases including MEDLINE, EMBASE, ISI Web of Knowledge, and the Cochrane Library from inception to December 2013 for randomized controlled trials (RCTs) that assessed the effect of SHE programs on walking ability in patients with PAD. Meta-analysis was performed based on the searched results, moreover, we made a systemic review regarding the results along with our knowledge.
RESULTS: Of all the 348 publications we got from the databases, 5 RCTs covering 547 patients reached the inclusion criteria and were involved in the present study. Both inverse-variance fixed-effects and random-effects model were used to perform meta-analysis. SHE programs improved MWT by mean difference of 66.78 sec (95% confidence interval [CI], 5.15-128.41; P = 0.03), heterogeneity across studies was significant. When the trial accounting for significant heterogeneity was omitted, SHE programs improved MWT by mean difference of 91.21 sec (95% CI, 51.96-130.45; P < 0.0001). In contrast, there was no significant heterogeneity across the studies with regard to PFWT and Walking Impairment Questionnaire (WIQ) score. SHE programs improved both PFWT and WIQ scores (mean difference of PFWT, 57.76s; 95% CI, 20.42-95.10; P = 0.002; mean difference of WIQ distance score, 8.67; 95% CI, 3.86-13.49; P = 0.0004; mean difference of WIQ speed score, 8.05, 95% CI, 4.46-11.64; P < 0.0001; mean difference of WIQ stair-climbing score, 6.44; 95% CI, 2.55-10.34; P = 0.001).
CONCLUSIONS: SHE programs improve walking ability in patients with PAD.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25449991     DOI: 10.1016/j.avsg.2014.10.010

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  5 in total

Review 1.  Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication.

Authors:  David Hageman; Hugo Jp Fokkenrood; Lindy Nm Gommans; Marijn Ml van den Houten; Joep Aw Teijink
Journal:  Cochrane Database Syst Rev       Date:  2018-04-06

2.  Effectiveness of self-managed home and community exercise interventions in improving physical activity, body adiposity and related health indices in adults living with HIV: a protocol for a systematic review.

Authors:  Jeannine Anyingu Aminde; Neil Harris; Caroline Thng; Ben Desbrow
Journal:  Syst Rev       Date:  2022-03-03

Review 3.  Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Barbara Riegel; Debra K Moser; Harleah G Buck; Victoria Vaughan Dickson; Sandra B Dunbar; Christopher S Lee; Terry A Lennie; JoAnn Lindenfeld; Judith E Mitchell; Diane J Treat-Jacobson; David E Webber
Journal:  J Am Heart Assoc       Date:  2017-08-31       Impact factor: 5.501

4.  Barriers and enablers to walking in individuals with intermittent claudication: A systematic review to conceptualize a relevant and patient-centered program.

Authors:  Ukachukwu Abaraogu; Elochukwu Ezenwankwo; Philippa Dall; Garry Tew; Wesley Stuart; Julie Brittenden; Chris Seenan
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

Review 5.  Cardiac Rehabilitation in Patients with Peripheral Artery Disease-A Literature Review in COVID-19 Era.

Authors:  Razvan Anghel; Cristina Andreea Adam; Dragos Traian Marius Marcu; Ovidiu Mitu; Florin Mitu
Journal:  J Clin Med       Date:  2022-01-14       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.